Research progress on platelets in glioma

Abstract. Gliomas are the most common primary neuroepithelial tumors of the central nervous system in adults, of which glioblastoma is the deadliest subtype. Apart from the intrinsically indestructible characteristics of glioma (stem) cells, accumulating evidence suggests that the tumor microenviron...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingrong Zuo, Tengfei Li, Zhihao Wang, Yufan Xiang, Siliang Chen, Yanhui Liu, Xiangxiang Pan
Format: Article
Language:English
Published: Wolters Kluwer 2025-01-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000003282
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550760072970240
author Mingrong Zuo
Tengfei Li
Zhihao Wang
Yufan Xiang
Siliang Chen
Yanhui Liu
Xiangxiang Pan
author_facet Mingrong Zuo
Tengfei Li
Zhihao Wang
Yufan Xiang
Siliang Chen
Yanhui Liu
Xiangxiang Pan
author_sort Mingrong Zuo
collection DOAJ
description Abstract. Gliomas are the most common primary neuroepithelial tumors of the central nervous system in adults, of which glioblastoma is the deadliest subtype. Apart from the intrinsically indestructible characteristics of glioma (stem) cells, accumulating evidence suggests that the tumor microenvironment also plays a vital role in the refractoriness of glioblastoma. The primary functions of platelets are to stop bleeding and regulate thrombosis under physiological conditions. Furthermore, platelets are also active elements that participate in a variety of processes of tumor development, including tumor growth, invasion, and chemoresistance. Glioma cells recruit and activate resting platelets to become tumor-educated platelets (TEPs), which in turn can promote the proliferation, invasion, stemness, and chemoresistance of glioma cells. TEPs can be used to obtain genetic information about gliomas, which is helpful for early diagnosis and monitoring of therapeutic effects. Platelet membranes are intriguing biomimetic materials for developing efficacious drug carriers to enhance antiglioma activity. Herein, we review the recent research referring to the contribution of platelets to the malignant characteristics of gliomas and focusing on the molecular mechanisms mediating the interaction between TEPs and glioma (stem) cells, as well as present the challenges and opportunities in targeting platelets for glioma therapy.
format Article
id doaj-art-4a08777f3f354184bd3b99ba2462c42c
institution Kabale University
issn 0366-6999
2542-5641
language English
publishDate 2025-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj-art-4a08777f3f354184bd3b99ba2462c42c2025-01-10T01:10:37ZengWolters KluwerChinese Medical Journal0366-69992542-56412025-01-011381283710.1097/CM9.0000000000003282202501050-00004Research progress on platelets in gliomaMingrong Zuo0Tengfei Li1Zhihao Wang2Yufan Xiang3Siliang Chen4Yanhui Liu5Xiangxiang Pan1 Department of Pediatric Neurosurgery, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China1 Department of Pediatric Neurosurgery, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China2 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China2 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China2 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China2 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, ChinaAbstract. Gliomas are the most common primary neuroepithelial tumors of the central nervous system in adults, of which glioblastoma is the deadliest subtype. Apart from the intrinsically indestructible characteristics of glioma (stem) cells, accumulating evidence suggests that the tumor microenvironment also plays a vital role in the refractoriness of glioblastoma. The primary functions of platelets are to stop bleeding and regulate thrombosis under physiological conditions. Furthermore, platelets are also active elements that participate in a variety of processes of tumor development, including tumor growth, invasion, and chemoresistance. Glioma cells recruit and activate resting platelets to become tumor-educated platelets (TEPs), which in turn can promote the proliferation, invasion, stemness, and chemoresistance of glioma cells. TEPs can be used to obtain genetic information about gliomas, which is helpful for early diagnosis and monitoring of therapeutic effects. Platelet membranes are intriguing biomimetic materials for developing efficacious drug carriers to enhance antiglioma activity. Herein, we review the recent research referring to the contribution of platelets to the malignant characteristics of gliomas and focusing on the molecular mechanisms mediating the interaction between TEPs and glioma (stem) cells, as well as present the challenges and opportunities in targeting platelets for glioma therapy.http://journals.lww.com/10.1097/CM9.0000000000003282
spellingShingle Mingrong Zuo
Tengfei Li
Zhihao Wang
Yufan Xiang
Siliang Chen
Yanhui Liu
Xiangxiang Pan
Research progress on platelets in glioma
Chinese Medical Journal
title Research progress on platelets in glioma
title_full Research progress on platelets in glioma
title_fullStr Research progress on platelets in glioma
title_full_unstemmed Research progress on platelets in glioma
title_short Research progress on platelets in glioma
title_sort research progress on platelets in glioma
url http://journals.lww.com/10.1097/CM9.0000000000003282
work_keys_str_mv AT mingrongzuo researchprogressonplateletsinglioma
AT tengfeili researchprogressonplateletsinglioma
AT zhihaowang researchprogressonplateletsinglioma
AT yufanxiang researchprogressonplateletsinglioma
AT siliangchen researchprogressonplateletsinglioma
AT yanhuiliu researchprogressonplateletsinglioma
AT xiangxiangpan researchprogressonplateletsinglioma